Nebraska football head coach says that bringing Dana Holgorsen aboard as offensive coordinator is all about getting the ...

From Bettina Bauer, Vice President, US HIV Treatment and Prevention, Gilead Sciences In 2022, there were up to 1.2 million ...

Westport failed to provide a resident medication to treat advanced HIV for three weeks, resulting in "significant medication ...

Gilead Sciences (NASDAQ:GILD) reported positive results from a pivotal Phase 3 study of its twice-yearly HIV prevention ...

Are you a print subscriber? Activate your account. By Garett Sloane - 3 min 8 sec ago By Ewan Larkin - 8 min 31 sec ago By ...

Data from a phase Ia clinical trial of an oral, long-acting integrase inhibitor (GS-1720) in development for HIV demonstrated ...

A new study from Tulane University finds that historical race-based lending practices are still impacting health today, ...

The BRAAVE2020 study investigated the efficacy of switching Black Americans living with HIV to a B/F/TAF single-pill regimen.

Serious questions are being raised about what led to the limited supply of crucial HIV medication, prompting the Health ...

This means you still have the HIV infection when early symptoms are gone. It’s important to get treatment for HIV to help ...

Highly effective treatments for HIV have existed since the mid-1990s. But while these treatments keep people healthy, we do not yet have a safe and scalable way to completely rid the body of the virus ...

The prevalence of liver steatosis was higher in people living with HIV compared with liver fibrosis, although both liver ...